Literature DB >> 27650724

Tumor lymphocytic infiltration in non-small cell lung cancer: the ultimate prognostic marker?

Laura Romero Vielva1.   

Abstract

Entities:  

Year:  2016        PMID： 27650724      PMCID： PMC5009091          DOI： 10.21037/tlcr.2016.07.07

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  21 in total

1.  TNM staging in colorectal cancer: T is for T cell and M is for memory.

Authors:  Elizabeth K Broussard; Mary L Disis
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

2.  Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis.

Authors:  Yiting Geng; Yingjie Shao; Wenting He; Wenwei Hu; Yanjie Xu; Jun Chen; Changping Wu; Jingting Jiang
Journal:  Cell Physiol Biochem       Date:  2015-10-30

3.  Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer.

Authors:  Tom Donnem; Sigurd M Hald; Erna-Elise Paulsen; Elin Richardsen; Samer Al-Saad; Thomas K Kilvaer; Odd Terje Brustugun; Aslaug Helland; Marius Lund-Iversen; Mette Poehl; Karen Ege Olsen; Henrik J Ditzel; Olfred Hansen; Khalid Al-Shibli; Yury Kiselev; Torkjel M Sandanger; Sigve Andersen; Francesco Pezzella; Roy M Bremnes; Lill-Tove Busund
Journal:  Clin Cancer Res       Date:  2015-02-13       Impact factor: 12.531

4.  Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

Authors:  Bernhard Mlecnik; Marie Tosolini; Amos Kirilovsky; Anne Berger; Gabriela Bindea; Tchao Meatchi; Patrick Bruneval; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès; Jérôme Galon
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

5.  Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.

Authors:  Khalid I Al-Shibli; Tom Donnem; Samer Al-Saad; Magnus Persson; Roy M Bremnes; Lill-Tove Busund
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

6.  High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.

Authors:  Isabelle Péguillet; Maud Milder; Delphine Louis; Anne Vincent-Salomon; Thierry Dorval; Sophie Piperno-Neumann; Suzy M Scholl; Olivier Lantz
Journal:  Cancer Res       Date:  2014-02-17       Impact factor: 12.701

Review 7.  The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.

Authors:  Roy M Bremnes; Lill-Tove Busund; Thomas L Kilvær; Sigve Andersen; Elin Richardsen; Erna Elise Paulsen; Sigurd Hald; Mehrdad Rakaee Khanehkenari; Wendy A Cooper; Steven C Kao; Tom Dønnem
Journal:  J Thorac Oncol       Date:  2016-02-01       Impact factor: 15.609

Review 8.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

9.  Objective measurement and clinical significance of TILs in non-small cell lung cancer.

Authors:  Kurt A Schalper; Jason Brown; Daniel Carvajal-Hausdorf; Joseph McLaughlin; Vamsidhar Velcheti; Konstantinos N Syrigos; Roy S Herbst; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2015-02-03       Impact factor: 11.816

10.  Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma.

Authors:  K Hiraoka; M Miyamoto; Y Cho; M Suzuoki; T Oshikiri; Y Nakakubo; T Itoh; T Ohbuchi; S Kondo; H Katoh
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640
View more
  3 in total

Review 1.  Prognostic and predictive biomarkers post curative intent therapy.

Authors:  Rebecca Feldman; Edward S Kim
Journal:  Ann Transl Med       Date:  2017-09

2.  Beneficial Effect of Fluoxetine and Sertraline on Chronic Stress-Induced Tumor Growth and Cell Dissemination in a Mouse Model of Lymphoma: Crucial Role of Antitumor Immunity.

Authors:  María Emilia Di Rosso; Helena Andrea Sterle; Graciela Alicia Cremaschi; Ana María Genaro
Journal:  Front Immunol       Date:  2018-06-19       Impact factor: 7.561

3.  p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma.

Authors:  Federica Giordano; Valentina Vaira; Diego Cortinovis; Sara Bonomo; Joyce Goedmakers; Federica Brena; Annamaria Cialdella; Leonarda Ianzano; Irene Forno; Maria Grazia Cerrito; Roberto Giovannoni; Gian Luca Ferri; Ennio Tasciotti; Silve Vicent; Francesco Damarco; Silvano Bosari; Marialuisa Lavitrano; Emanuela Grassilli
Journal:  J Exp Clin Cancer Res       Date:  2019-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.